Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Endometrioid carcinoma of the endometrium with an invasive component of minimal deviation carcinoma.

Mai KT, Perkins DG, Yazdi HM, Thomas J.

Hum Pathol. 2002 Aug;33(8):856-8.

PMID:
12203221
2.

Endometrioid adenocarcinoma of the uterus with a minimal deviation invasive pattern.

Landry D, Mai KT, Senterman MK, Perkins DG, Yazdi HM, Veinot JP, Thomas J.

Histopathology. 2003 Jan;42(1):77-82.

PMID:
12493029
4.

'Minimal deviation' endometrioid carcinoma with oncocytic change of the endometrium.

Mai KT, Yazdi HM, Boone SA.

Arch Pathol Lab Med. 1995 Aug;119(8):751-4.

PMID:
7544107
6.

Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.

Demopoulos RI, Mesia AF, Mittal K, Vamvakas E.

Int J Gynecol Pathol. 1999 Jul;18(3):233-7.

PMID:
12092593
7.
8.

Minimal deviation endometrioid adenocarcinoma of the endometrium and its MRI findings.

Nakao Y, Yamasaki F, Yokoyama M, Aihara S, Yasunaga M, Iwasaka T.

Eur J Gynaecol Oncol. 2014;35(2):185-7.

PMID:
24772926
9.

The immunohistochemical discrimination of endometrioid adenocarcinomas.

Dabbs DJ, Sturtz K, Zaino RJ.

Hum Pathol. 1996 Feb;27(2):172-7.

PMID:
8617459
11.

Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix: a case report.

Park HM, Lee SS, Eom DW, Kang GH, Yi SW, Sohn WS.

J Korean Med Sci. 2009 Aug;24(4):767-71. doi: 10.3346/jkms.2009.24.4.767. Epub 2009 Jul 30.

12.
13.

[Mathematical evaluation of prognostic significance of clinico-morphological and immunohistochemical features of endometrioid adenocarcinoma].

Razorenova TS, Samsonova EA, Pozharisskiń≠ KM, Razorenov GI.

Vopr Onkol. 2007;53(6):682-9. Russian.

PMID:
18416138
14.

Cytopathological observations in a 27-year-old female patient with endometrioid adenocarcinoma arising in the lower uterine segment of the uterus.

Masuda K, Yutani C, Akutagawa K, Yamamoto S, Ishibashi-Ueda H, Imakita M, Takeda M, Kurata A, Hayashi T, Sasaki M.

Diagn Cytopathol. 1999 Aug;21(2):117-21.

PMID:
10425049
15.

Minimal deviation adenocarcinoma of the uterine cervix has abnormal expression of sex steroid receptors, CA125, and gastric mucin.

Toki T, Shiozawa T, Hosaka N, Ishii K, Nikaido T, Fujii S.

Int J Gynecol Pathol. 1997 Apr;16(2):111-6.

PMID:
9100063
16.

Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report.

Shen Y, Wang Y, Shi Y, Liu J, Liu Y.

Int J Clin Exp Pathol. 2012;5(1):77-82. Epub 2012 Jan 1.

17.

Microglandular adenocarcinoma of the uterus mimicking microglandular cervical hyperplasia.

Zamecnik M, Skalova A, Opatrny V.

Ann Diagn Pathol. 2003 Jun;7(3):180-6.

PMID:
12808571
18.

CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.

Ohishi Y, Kaku T, Kobayashi H, Aishima S, Umekita Y, Wake N, Tsuneyoshi M.

Hum Pathol. 2008 Oct;39(10):1446-53. doi: 10.1016/j.humpath.2008.02.006. Epub 2008 Jul 11.

PMID:
18619643
19.

Invasive adenocarcinoma arising from uterine adenomyosis involving the rectosigmoid colon.

Takeuchi K, Yamanaka Y, Hamana S, Ohara N, Maruo T.

Int J Gynecol Cancer. 2004 Sep-Oct;14(5):1004-6.

PMID:
15361215
20.

Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.

Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA.

Mod Pathol. 2006 Aug;19(8):1091-100. Epub 2006 Apr 28.

Supplemental Content

Support Center